Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Barinthus Biotherapeutics (BRNS) over the last 3 years, with Q3 2025 value amounting to $4.7 million.

  • Barinthus Biotherapeutics' Other Operating Expenses changed N/A to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year change of. This contributed to the annual value of $12.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Other Operating Expenses is $4.7 million.
  • Over the past 5 years, Barinthus Biotherapeutics' Other Operating Expenses peaked at $19.4 million during Q4 2022, and registered a low of -$10.8 million during Q3 2022.
  • Moreover, its 3-year median value for Other Operating Expenses was $4.7 million (2025), whereas its average is $3.9 million.